Spinos Life Science And Research Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.49 M
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.89 Cr
- Revenue Growth 10.42%
- Profit Growth 67.90%
- Ebitda 4222.85%
- Net Worth 35.80%
- Total Assets 38.59%
About Spinos Life Science And Research
Spinos Life Science And Research Private Limited (SLSARPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 30 March 2016 (Eight years and ten months 24 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.49 M.
The company has closed loans amounting to ₹2.89 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Veerappan Ramapalaniappan, Dheer Shah, Aravind Badiger, and Two other members serve as directors at the Company.
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85200TZ2016PTC027449
- Company No.
027449
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2016
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
What products or services does Spinos Life Science And Research Private Limited offer?
Spinos Life Science And Research Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Medical Consultants & Clinics, Medical Consultancy Services, Educational Services.
Who are the key members and board of directors at Spinos Life Science And Research?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ramapalaniappan Abiraamasundari ![]() | Managing Director | 30-Mar-2016 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Raheel Shah ![]() | Director | 18-Dec-2023 | Current |
Veerappan Ramapalaniappan ![]() | Director | 17-Sep-2018 | Current |
Dheer Shah ![]() | Director | 18-Dec-2023 | Current |
Aravind Badiger ![]() | Director | 18-Dec-2023 | Current |
Financial Performance of Spinos Life Science And Research.
Spinos Life Science And Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.42% increase. The company also saw a substantial improvement in profitability, with a 67.9% increase in profit. The company's net worth Soared by an impressive increase of 35.8%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Spinos Life Science And Research?
Unlock access to Spinos Life Science And Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)
₹0
₹28.88 M
Charges Breakdown by Lending Institutions
- Others : 2.69 Cr
- Tamilnad Mercantile Bank Limited : 0.20 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Feb 2023 | Others | ₹1.00 Cr | Satisfied |
02 Feb 2023 | Others | ₹1.69 Cr | Satisfied |
30 Dec 2016 | Tamilnad Mercantile Bank Limited | ₹2.00 M | Satisfied |
How Many Employees Work at Spinos Life Science And Research?
Spinos Life Science And Research has a workforce of 76 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Spinos Life Science And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spinos Life Science And Research's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.